413 IBR403, a novel small molecule, enables scalable manufacturing of HSC-derived natural killer cells for cancer immunotherapy

• Nina Horowitz,
• Shyama Chaganti,
• Bauer LeSavage,
• Stefanie Mauer,
• James Liu,
• Peretz Partensky,
• Jesse Cotari

Affiliations

Nina Horowitz

Stanford University, Stanford, CA, USA

Shyama Chaganti

ImmunBridge, San Francisco, CA, USA

Bauer LeSavage

ImmunBridge, San Francisco, CA, USA

Stefanie Mauer

ImmunBridge, San Francisco, CA, USA

James Liu

ImmunBridge, San Francisco, CA, USA

Peretz Partensky

ImmunBridge, San Francisco, CA, USA

Jesse Cotari

ImmunBridge, San Francisco, CA, USA